nlmixr2 7.0’s Covariance Step, All Grown Up

The nlmixr2 Working Group explains full covariance-step support in nlmixr2 7.0, including every estimated parameter and switching covariance methods without refitting.
pharma
submissions
clinical research
announcements
working groups
Author

R Consortium

Published

August 26, 2026

The nlmixr2 logo: a hexagonal sticker with a red border featuring nlmix in dark blue and r squared in red, with www.nlmixr2.org along the bottom edge

Original post on the nlmixr2 project blog is here.

The nlmixr2 Working Group continues to expand what open-source R tooling can support in pharmacometrics. In a follow-up to the nlmixr2 7.0 release post, Matthew Fidler focuses on a frequently requested feature: a full covariance step, plus other refinements to how covariance is computed after a fit.

Two related changes stand out. Nearly any covariance method can now be requested from nearly any estimation method, and you can switch a finished fit to a different covariance method without refitting. The default covariance step also now covers every estimated parameter - not just the structural ones - so residual-error terms can return standard errors, %RSE, and confidence intervals in $parFixed the way users expect.

Read the full post from the nlmixr2 blog: nlmixr2 7.0’s covariance step, all grown up

Why nlmixr2?

The vision of nlmixr2 is to develop a R-based open-source nonlinear mixed-effects modeling software package that can compete with commercial pharmacometric tools and is suitable for regulatory submissions.

In short, the goal of nlmixr2 is to support easy and robust nonlinear mixed effects models in R.

From: https://github.com/nlmixr2/nlmixr2

Get involved in the nlmixr2 working group

The nlmixr2 working group is open to anyone interested in contributing to the project. You can get involved by:

Main repo: https://github.com/nlmixr2/nlmixr2
Issues: https://github.com/nlmixr2/nlmixr2/issues
Discussions: https://github.com/nlmixr2/nlmixr2/discussions